Chris Hanson

Chris Hanson is a versatile professional with extensive experience across various sectors. Currently serving as a juror and mentor at the Berkeley Defense Impact Accelerator, Chris supports companies focused on cutting-edge defense technology. As a cofounder and Chief Strategy & Development Officer at Olfactive Biosolutions, Chris is pioneering the use of food ingredient formulations for health applications. Additional advisory roles include strategic guidance at Juji, Inc., Trio Pharmaceuticals, Inc., and Gryphon Bio, Inc., where Chris contributes to advancements in AI, cancer treatment, and precision medicine. Chris also played a key role in the StartX Med COVID-19 Task Force at Stanford University School of Medicine. Previous leadership experience includes founding Aromyx Corporation and a senior role at IBM Research. Chris holds both a Master's and Bachelor's degree in Applied Linguistics from Stanford University.